Can Digital Women’s Health go beyond D2C?

Why do most femtech businesses start with a D2C approach? While Digital Health for women is still at the beginning of the journey, investors are starting to see a great opportunity considering the big reach these solutions might have and women’s engagement with health and wellbeing (80% of health decisions are made by women). However, most of these digital health solutions are D2C. Why is that and how successful has this been to date? As innovators start exploring areas beyond fertility and contraception (e.g PCOS, endometriosis, mental health, etc), other commercialization models might make more sense (e.g partnerships with pharma, health systems, employers, etc). Join us in this meeting to have an informal conversation with other senior leaders about: